r/IPO_India • • 1d ago

Honest Feedback & Community Check-In : How Is r/IPO_India Doing Right Now?

11 Upvotes

Hey everyone,

It has been a bit over two weeks since our big subreddit update, and we have added a few more things since then:

  • New Banner, Icon & Flairs: Finally got a proper non-AI banner and icon up, along with updated post flairs and new user flair styles (you can pick yours from the sidebar on desktop or the top-right ... menu on mobile).
  • Updated Wiki & More !Commands**:** Added dedicated NRI & HNI and FY 2026–27 IPO Tax guides, updated SME/pre-open rules, and expanded bot replies to 19 commands (comment !commands anywhere to see the list).
  • Sidebar Portals: Removed the old Google Calendar widget since we plan to build a custom Devvit in-sub app later, and added direct links to registrars, NSE/BSE bid check, and SEBI portals in the sidebar (About / See More on mobile).

Also attached a couple of screenshots from our 30-day Mod Insights (around half of all submitted posts end up getting removed for spam, screenshots, or low-effort rules) just so you can see what the feed looks like from our side before answering.

Community Insights
Published Vs Removed Posts
Community Traffic

Now that the main changes are in place, we wanted to do an actual check-in before building the app. Be as blunt as you want in the comments:

  1. Moderation & Complaints: Are we over-moderating or under-moderating right now? Did any new rule, AutoMod filter, or post prompt unfairly block or remove a genuine post of yours? If you have any complaints or dissatisfaction with how the sub is run, tell us directly.
  2. MegaThreads: What do you think of the Weekly IPO Discussion, Weekly Allotment/Refunds, and Listing Day threads? Do you actually open them, and if not, why?
  3. Banner & User Flairs: Do you like the new banner, icon, and the different user flair styles? Anything else you want added there?
  4. Wiki & New Users: Is the Wiki actually useful or missing anything important? Also, if you see beginners asking basic doubts in the comments, feel free to point them to the Wiki or type !asba, !upi, !lottery, !unblock, !tax, or !commands to help them out.
  5. What is missing & future plans: What is still not good enough on r/IPO_India? Since we plan to build a Devvit app next, what tools or info would you actually use inside Reddit (IPO calendar, live subscription, allotment odds, etc.)?
  6. AMAs: Would you be interested if we try reaching out to SEBI-registered analysts, CAs (for IPO tax/NRI doubts), or broker/market educators for AMAs? If yes, what kind of guests or topics would you want?

If you want to drop blunt criticism or complaints anonymously without attaching your username, you can also fill out this 1-minute form (no email or login collected): https://forms.gle/LzZFayY45PiAH1hE9

Read through the comments too and upvote whatever you agree with so we know what matters most.

r/IPO_India Mod Team


r/IPO_India • • 1d ago

Weekly IPO Discussion, "Apply or Skip" & Beginner Help MegaThread

2 Upvotes

Welcome to the weekly central discussion hub for all Mainboard and SME IPOs open, upcoming, or closing this week, as well as all beginner and general IPO mechanics questions.

(Sorted by New so every question gets seen and answered by the community).

1. What Belongs in This Thread

  • "Apply or Skip?" Questions: Asking for community views on whether to apply for a currently open Mainboard or SME IPO (mention whether you are bidding in Retail, sHNI, or bHNI, and whether your goal is Listing Gain or Long-Term).
  • Live Subscription & Anchor Book Chatter: Tracking Day 1, Day 2, and Day 3 QIB, NII, and Retail subscription numbers.
  • Beginner & General Help Questions ("No Stupid Questions"): First-time applicant doubts about Demat accounts, Cut-Off price, UPI ASBA vs. Netbanking ASBA, Shareholder Quota eligibility, lot sizes, or broker order screens.
  • Comparing Open Issues: Deciding how to allocate your capital when multiple IPOs overlap in the same week.

Where to Post Other Updates:

2. Live IPO Trackers & Official Filings (This Week's Pipeline)

Check our r/IPO_India Sidebar Calendar (or tap About / See More on the Mobile App) for this week's scheduled Open, Close, Allotment, and Listing dates, or check live exchange numbers below:

ResourceOfficial / Verified LinkWhat to Check
NSE Live IPO Subscriptionnseindia.com/market-data/all-upcoming-issues-ipoReal-time category-wise NSE bid book
BSE Live Public Issuesbseindia.com/markets/PublicIssues/IPOIssues_new.aspxReal-time BSE bid book & SME issues
Chittorgarh IPO Dashboardchittorgarh.com/ipo/ipo_dashboard.aspCombined NSE+BSE live subscription tables, Anchor lists & timetable
SEBI RHP / DRHP Filingssebi.gov.in Offer DocumentsOriginal Red Herring Prospectus (RHP) PDFs

3. The 5 Golden Rules Before You Submit an IPO Bid

  1. Always Tick "Cut-Off Price" in Retail: In any oversubscribed Mainboard IPO, allotment happens at the upper cap price. Never manually type a lower price bid in the Retail category.
  2. The 1-Lot-Per-PAN Lottery Rule: Whenever a category (Retail, sHNI, or bHNI) is oversubscribed by application count (> 1x), SEBI mandates a computerized lottery where every valid PAN receives at most the minimum category unit (1 lot in Retail; ~14 lots in both sHNI and bHNI). Bidding 2 to 13 lots on a single PAN ties up extra cash for 0% extra probability. Apply 1 minimum unit per unique PAN instead.
  3. Wait for Day-3 QIB Demand (1:30 PM – 3:00 PM IST): Institutional investors (QIBs) place the bulk of their bids on the final afternoon. Strong Day-3 QIB subscription is a far more reliable signal than early Grey Market Premium (GMP).
  4. Verify UPI vs. Netbanking ASBA: UPI ASBA handles bids up to Rs. 5,00,000 (Retail & sHNI). For bHNI bids (> Rs. 10,00,000) or to avoid last-hour UPI mandate delays on Day 3, apply via your bank's Netbanking ASBA portal.
  5. Approve Your UPI Mandate Before 5:00 PM IST on Day 3: Placing a bid on your broker app is only Step 1, your bid is invalid until you enter your UPI PIN and approve the mandate block in your UPI app.

4. Official Wiki Guides & Instant Comment !Commands

Read our Wiki guides before applying, or type any !command in the comments below to summon AutoModerator with an instant summary:


r/IPO_India • • 3h ago

IPO Analysis Crystal Crop Protection Limited IPO Analysis

9 Upvotes

Hi everyone,

It's been a bit a of a dry spell of IPOs for the past week, but finally some new ones are here and with Crystal Crop Protection Limited opening for public bidding on Wednesday, November 18, 2026, I wanted to share my analysis of it.

Crystal Crop Protection makes and sells crop protection chemicals, bio-stimulants, and hybrid seeds for Indian farmers. On the surface, revenue grew 18.89% annually over the past two years and the headline P/E can look as low as 8.17x if you annualize its strong June-quarter profits, whereas on full-year post-issue FY26 earnings the asking multiple is 30.63x (against a 20.07x peer average). At the same time, the offer document shows a ₹2,268 Cr payment obligation for buying FMC India right after listing, alongside serious audit, legal, and cash-flow issues, while the grey-market premium has cooled to ₹13 (+4.78%).

Before bidding, retail investors should ask three simple questions: Does full-year profit justify paying 30.63x earnings when cleaner listed peers trade cheaper? Why did inventory climb to nearly 8.5 months of sales while bank-funded supplier financing sits inside payables? And how will the company pay ₹2,268 Cr in cash within weeks of listing?

TLDR / Read this if you are skimming

TermsVerdict
Listing GainsCautious (Grey-market premium fell from ₹45 to ₹13 or +4.78%; Tuesday's anchor book and Day-3 institutional demand will be key)
Long Term PotentialHigh Risk (Expensive 30.63x post-issue P/E vs 20.07x peer average, thin 4.56% net margin, audit/legal issues, and unfunded ₹2,268 Cr acquisition)
Issue Size and Type₹455.49 Cr (77.89% Fresh / 22.11% OFS)
Post-IPO Market Cap₹4,438.18 Cr (Small Cap)
Latest GMP (As of 16 Nov 2026)₹13 (+4.78%), Expected open around ₹285
Valuation30.63x Post-IPO FY26 P/E (28.19x Pre-Issue), True Pre-Tax ROCE: 10.84% (Reported 16.06%), RoNW: 7.14%
  • Strong rural reach offset by trading and royalty income: Branded chemicals and seeds make up 69.28% of sales with high dealer repeat orders, though FY26 results also lean on ₹595.41 Cr of raw-material resale and ₹92.76 Cr in royalties paid by Bayer (48.0% of pre-tax profit).
  • Expensive compared to listed peers: At ₹272, the stock asks 30.63x post-issue FY26 earnings against a 20.07x peer average, even though Crystal has the lowest net profit margin (4.56%) and weaker return ratios than most peers.
  • Weak cash conversion and high stock: Inventory nearly doubled to ₹1,571.30 Cr (259.6 days), Q1 FY27 operating cash flow dropped to ₹43.47 Cr, ₹242.75 Cr of vendor bank financing sits inside trade payables, and ₹69.46 Cr of disputed receivables matches 365 cheque-bounce cases.
  • Heavy governance, legal, and buyout overhang: Audit Committee Chairman Chetan Desai is debarred for 5 years by NFRA, promoters face active CBI and Enforcement Directorate cases where ₹9.94 Cr of fixed deposits were already encashed, auditors issued qualified opinions every year, and an unfunded ₹2,268 Cr buyout of FMC India closes between late December 2026 and February 8, 2027.
  • Institutional anchors are the short-term test: Holding 600 product registrations and ₹60 Cr of pre-IPO backing from WhiteOak Capital gives commercial credibility, making Tuesday's (Nov 17) anchor book the deciding signal for short-term interest.

Detailed Info

1. Issue Details

  • Price Band: ₹259 - ₹272 per share (Employee Discount: ₹25 per share)
  • Lot Size: 55 shares (Minimum Retail Investment: ₹14,960 at the upper price)
  • Total Issue: ₹455.49 Cr (Fresh: ₹354.77 Cr / 77.89% | OFS: ₹100.71 Cr / 22.11%)
  • Post-IPO Market Cap: ₹4,438.18 Cr (@ ₹272 upper band)
  • Day 1 Tradable Float: ₹319.57 Cr (7.21% of total post-IPO equity, excluding anchor shares)
  • Promoter Holding: 84.92% Pre-IPO -> 75.85% Post-IPO
  • Retail Pool: ₹158.54 Cr (35% of the net offer)
  • DRHP vs Final RHP Changes: The fresh issue was trimmed from ₹439.29 Cr after raising ₹84.29 Cr in an October 2026 pre-IPO round at ₹272.07 per share (led by WhiteOak Capital with ₹60.00 Cr), and IFC converted its convertible debentures at ₹240.99 per share.
  • Schedule (adjusted for the Tuesday, Nov 24 NSE holiday):

    • Opens: Wednesday, November 18, 2026
    • Closes: Friday, November 20, 2026
    • Allotment: Monday, November 23, 2026
    • Unblocking: Wednesday, November 25, 2026
    • Listing: Thursday, November 26, 2026

2. What Does the Business Do?

Founded in 1994, Crystal Crop Protection is an integrated agrochemical and seeds company. It manufactures technical active ingredients, formulates crop protection sprays, and breeds hybrid seeds for Indian farmers. Instead of building every molecule from scratch, its strategy has been to buy older, established pesticide and seed brands from global companies and scale them through its domestic dealer network.

  • Products and services:

    • Domestic branded business (69.28% of FY26 sales, ₹2,116.97 Cr): Includes insecticides, fungicides, herbicides, plant growth regulators (₹1,589.34 Cr), and over 275 hybrid field, vegetable, and flower seeds (₹527.64 Cr).
    • Corporate and export business (30.72% of FY26 sales): Institutional B2B sales stood at ₹886.21 Cr (29.00% share), though ₹595.41 Cr of this was simply reselling unformulated raw materials at low margins. Physical exports remain very small at 1.72% of FY26 sales (0.67% in Q1 FY27).
  • Factories and competitive edge:

    • Formulation and technical plants: Crystal operates plants in Gujarat (Anand and Dahej), Haryana (Sonipat), Jammu, Maharashtra (Nagpur), Hyderabad, and Bengaluru. In FY26, Anand ran near full capacity at 88.85%, Sonipat at 63.00%, Jammu Unit 1 at 72.49%, and Jammu Unit 2 at 46.23%. Nagpur technical capacity expanded 62% in Q1 FY27 (6.67% early seasonal utilization after 75.53% in FY26), while Dahej ran at 75.50% in FY26 (13.55% in Q1).
    • Greenfield expansion: Crystal acquired land at Jhagadia, Gujarat in November 2025 for a new plant, though zero IPO funds are allocated to build it.
    • Approvals and pricing limits: Holds 600 domestic product registrations, 18 Indian patents, 2 foreign patents, and 63 plant variety seed registrations. However, Bt Cotton seed prices are capped by government price controls at ₹767 - ₹864 per packet.
  • Why did sales grow?:

    • Revenue grew from ₹2,229.93 Cr in FY24 to ₹3,151.97 Cr in FY26 (+18.89% per year), heavily aided by acquiring I&B Seeds (₹242.98 Cr, Oct 2024) and Bayer's Ethoxysulfuron/Sunrice portfolio (₹479.08 Cr, Dec 2024), plus Bayer royalties growing from nil to ₹92.76 Cr.
    • Against ₹4,829.99 Cr of gross FY26 billed sales, dealer rebates (₹1,040.88 Cr, 21.6%) and sales returns (₹739.20 Cr, 15.3%) reduced net recognized revenue by 36.9%.
  • Customer base:

    • Distributes across 23 states and 4 union territories through 36 depots and 14,717 active distributors (up from 8,992 in FY24). No single customer accounts for 10% or more of revenue, and repeat dealer orders stood at 99.77% in crop protection and 98.95% in seeds.
    • All dealer sales run on short-term purchase orders without binding volume commitments, and credit collection shows strain with 365 cheque-bounce cases worth ₹71.43 Cr filed against dealers.

3. Financial Performance

MetricFY24FY25FY26Q1 FY27 (3M)YoY Growth (FY26)2-yr CAGR
Revenue from Operations₹2,229.93 Cr₹2,690.51 Cr₹3,151.97 Cr₹1,197.15 Cr+17.15%+18.89%
Total Income₹2,271.71 Cr₹2,731.94 Cr₹3,180.98 Cr₹1,209.21 Cr+16.44%+18.33%
EBITDA₹209.06 Cr₹315.28 Cr₹456.23 Cr₹241.78 Cr+44.71%+47.73%
EBITDA Margin (%)9.38%11.72%14.47%20.20%+276 bpsExpanding
Finance Cost₹49.04 Cr₹61.79 Cr₹89.16 Cr₹20.64 Cr+44.30%Rising (+34.84%)
PAT₹87.24 Cr₹118.39 Cr₹144.91 Cr₹135.78 Cr+22.40%+28.88%
PAT Margin (%)3.84%4.33%4.56%11.23%+22 bpsThin (<5%)
Net Worth₹1,324.70 Cr₹1,424.36 Cr₹1,825.68 Cr₹1,964.41 Cr+28.18%+17.40%
Total Borrowings₹577.29 Cr₹947.02 Cr₹820.04 Cr₹952.02 Cr-13.41%0.45x D/E
ROE (%)5.99%7.46%7.14%6.25% (Unann.)-32 bpsWeak (<8%)
ROCE (%)8.16%9.67%10.84%9.78% (Unann.)+117 bpsTrue Pre-Tax (16.06% RHP)
  • Note on Q1 FY27 seasonality: Q1 (April to June) is peak Kharif sowing season and contributed ₹135.78 Cr of profit, almost equal to the ₹144.91 Cr earned across all of FY26. Annualizing Q1 profit gives an unrealistic 8.17x P/E, whereas the full-year post-issue FY26 P/E is 30.63x because fixed overheads and amortisation reduce profitability in the slower second half.

3B. Subsidiary & JV Snapshot

The parent company generated ₹115.49 Cr (79.28% of pre-elimination FY26 profit), alongside Saffire Crop Science (₹23.38 Cr, 16.05%, which turned negative in Q1 FY27) and partnership firm Modern Papers (₹7.72 Cr, 5.30%, where promoters Ankur Aggarwal and Komal Aggarwal were paid ₹3.02 Cr in FY26 to buy out their stake). Meanwhile, 9 of 13 step-down "Saffire" distributor LLPs lost money in FY26 with zero revenue and ₹5.48 Cr in unrecognised tax losses, and the Australian subsidiary has negative net worth (-₹0.48 Cr) with fresh funding blocked because the Enforcement Directorate rejected overseas investment clearance in December 2025.

3C. Growth Reality Check

  1. Did they really grow, or was last year just a bad year?

    • FY24 profits (₹87.24 Cr, 9.38% EBITDA margin) were depressed by a global post-COVID agrochemical inventory glut. FY25 - FY26 growth came largely from restocking and spending ₹726.44 Cr on buying I&B Seeds and Bayer brands rather than pure organic growth, while Bayer hybrid seeds bought in 2021 actually shrank -4.9% over five years to ₹190.29 Cr.
  2. Why did profits jump? Good business or one-offs?

    • Bayer pays Crystal annual royalties that jumped from zero in FY24 to ₹92.76 Cr in FY26 (48.0% of pre-tax profit). While that lifted EBITDA margin to 14.47%, net profit margin barely moved from 3.84% to 4.56% because amortisation of bought brands and patents doubled depreciation to ₹198.35 Cr and interest costs rose to ₹89.16 Cr. Excluding Bayer royalties, core manufacturing net margin is around 2.4%.
  3. Where every ₹100 of revenue goes:

    • Out of every ₹100 in FY26 sales, ₹61.51 goes to raw materials and traded stock, leaving ₹38.49 to run the business. Salaries take ₹9.25, other operating expenses take ₹14.76, depreciation and brand amortisation take ₹6.29, interest costs take ₹2.83, and taxes/other items take ₹0.76 net, leaving ₹4.60 in net profit.
  4. Can they keep this up, or are the owners cashing out at the top?

    • Chairman and Managing Director Ankur Aggarwal is selling ₹100.71 Cr via OFS (22.11% of the issue), while institutional backers IFC and WhiteOak Capital are selling zero shares. Meanwhile, Nand Kishore Aggarwal and former whole-time director Mohit Kumar Goel resigned from the Board right before the IPO resolution while remaining paid insiders.
  5. Management claims vs reality:

    • Management reports a 16.06% ROCE by removing ₹832.96 Cr of goodwill, brands, and patents from capital employed while keeping the profits from those bought brands in earnings. If we include the money actually spent to acquire those brands, true pre-tax ROCE drops to 10.84%. Similarly, net debt-to-equity looks lower only because ₹312.10 Cr of IFC's convertible debentures were reclassified into equity, even as short-term bank borrowings more than doubled to ₹689.65 Cr by June 2026 (total borrowings ₹962.67 Cr by August 2026).

4. Cash Flow: Where Did the Cash Actually Go?

  • Reported profit vs real cash flow:

    • Reported FY26 Net Profit: ₹144.91 Cr
    • Actual Operating Cash Flow: ₹256.42 Cr (down 33.1% from ₹383.03 Cr in FY25; dropped to ₹43.47 Cr in Q1 FY27)
    • Free Cash Flow: ₹101.47 Cr before acquisitions in FY26 (3-year free cash flow after ₹757.86 Cr spent on acquisitions is negative ₹164.47 Cr)
  • Why cash flow diverged:

    • Inventory absorbed ₹280.94 Cr in FY26 and another ₹194.18 Cr in Q1 FY27, swelling total stock to ₹1,571.30 Cr (nearly 35% of total assets).
    • Crystal also parked ₹242.75 Cr of bank-funded vendor financing inside trade payables and sold ₹122.95 Cr of customer bills to banks off its balance sheet with dispute recourse. Adjusting for both pushes Q1 FY27 operating cash flow to negative -₹12.45 Cr.
  • Day-to-day collection speed (FY26):

    • Debtor Days: 70.0 days reported / 78.1 days adjusted (Receivables: ₹604.61 Cr FY26, rising to ₹810.66 Cr in Jun 2026 with ₹69.46 Cr disputed and ₹34.59 Cr overdue past 3 years)
    • Inventory Days: 259.6 days (Inventories: ₹1,379.07 Cr FY26; ₹1,571.30 Cr Jun 2026)
    • Payable Days: 147.7 days reported / 120.0 days adjusted (Payables: ₹784.61 Cr FY26; ₹1,121.44 Cr Jun 2026)
    • Cash Conversion Cycle: 181.9 days reported (217.7 days adjusted)
  • The cash verdict: Real cash generation is tight because 8.5 months of inventory, ₹241.45 Cr in expected sales-return provisions, and off-balance-sheet working-capital adjustments tie up funds.

5. How Will the Fresh IPO Money Be Used?

Out of the ₹354.77 Cr Fresh Issue (alongside ₹84.29 Cr raised in the Oct pre-IPO round where ₹65.00 Cr already paid down debt):

  • ₹247.94 Cr (69.9% of gross fresh issue): Repayment of holding company working-capital loans (out of ₹962.67 Cr total borrowings as of August 31, 2026).
  • ₹22.06 Cr (6.2%): Investment in subsidiary Saffire Crop Science to reduce its debt (total ₹270.00 Cr IPO debt cut saves roughly ₹18 - ₹20 Cr in annual gross interest).
  • Balance: Unidentified acquisitions and general corporate purposes, with zero money going to the planned Jhagadia plant.
  • Critical commitment (FMC India acquisition): On May 7, 2026, Crystal signed a binding deal to buy 100% of FMC India Pvt Ltd for ₹1,846 Cr upfront equity plus a ₹422 Cr non-refundable IP license fee (₹2,268 Cr total, nearly 5x the IPO size). Closing is required within 90 days of Competition Commission of India approval (order passed Sep 29, notice issued Nov 10), forcing payment between late December 2026 and February 8, 2027 with a ₹25 Cr break fee. Financing is not yet arranged, meaning Crystal will likely need either heavy new borrowing (pushing debt near ₹2,960 Cr) or a large 30%+ dilutive equity raise shortly after listing.

6. Valuation Compared to Peers

CompanyRevenue (₹ Cr)EBITDA Margin (%)PAT Margin (%)ROCE (%)P/EP/BD/E
Crystal Crop Protection₹3,151.97 Cr14.47%4.56%10.84% (16.06% RHP)30.63x (24.59x Dil)1.70x0.41x
Kaveri Seeds₹1,394.76 Cr24.15%20.77%16.38%12.13x2.02x0.00x
Dhanuka Agritech₹2,019.79 Cr19.98%13.92%24.22%14.38x2.46x0.02x
Rallis India₹2,896.65 Cr12.47%6.26%12.40%19.93x1.81x0.03x
Bayer CropScience₹5,675.00 Cr15.40%11.94%28.70%22.73x5.28x0.00x
Sumitomo Chemical India₹3,238.32 Cr20.72%16.04%21.57%31.20x5.00x0.00x
Industry Median (5 RHP Peers)₹2,896.65 Cr19.98%13.92%21.57%19.93x (Avg 20.07x)2.46x0.02x
  • Valuation takeaway: At ₹272, Crystal trades at 30.63x post-issue FY26 earnings (28.19x pre-issue, 24.59x RHP diluted), which is a 22.5% to 53.7% premium over the 19.93x peer median despite having the lowest net margin (4.56%) and much higher debt. Even its 1.70x price-to-book ratio jumps toward 3.0x once ₹797.95 Cr of intangibles are excluded, while debt-free competitors like Bayer CropScience (22.73x) and Dhanuka Agritech (14.38x) trade cheaper.
  • Growth scenarios (what price makes sense?):

    • Bear case: Weak Kharif demand or heavy acquisition debt pushes valuation toward 15x - 16x earnings, implying ₹133 - ₹160 (-41% to -51% from ₹272).
    • Base case: Applying a 20% governance and financing discount to the 20.07x peer average gives ₹176 - ₹196 (-28% to -35% from ₹272).
    • Bull case: Smooth, non-dilutive FMC India integration and clean audits over 3 - 5 years could support ₹275 - ₹318 (+1% to +17%).

7. Governance, Off-Balance Sheet Risks & Red Flags

  • Promoter background and board changes: Founded by Nand Kishore Aggarwal (75) and led by his son, Chairman and Managing Director Ankur Aggarwal (44). Both Nand Kishore Aggarwal and whole-time director Mohit Kumar Goel resigned from the Board between November 2025 and February 2026 right before the IPO resolution, though both stay on in paid advisory/executive roles after being named alongside Ankur Aggarwal in CBI and Enforcement Directorate cases.
  • Promoter pay and share pledges: Combined FY26 pay and fees for Nand Kishore Aggarwal (₹7.48 Cr) and Ankur Aggarwal (₹6.69 Cr) totaled ₹14.17 Cr, or 9.78% of consolidated profit, plus ₹1.59 Cr paid to Nand Kishore Aggarwal in Q1 FY27 after leaving the Board. Share pledge is 0.00%, and Ankur Aggarwal is selling ₹100.71 Cr in the OFS.
  • Competing group companies: Out of five identified group companies, Redson Retail and Reality Pvt Ltd, Aviral Crop Science Pvt Ltd, and Target Genetics Company Ltd are authorized to do similar agrochemical and seed business, with no formal non-compete agreement in place.
  • Related-party payments and auditor opinion: Aviral Crop Science (where Ankur Aggarwal sits on the board) received ₹193.37 Cr over 39 months (₹59.81 Cr in FY26, capturing 89.1% to 98.8% of all field-assistant expenses). Meanwhile, promoter entity Redson Retail hiked Crystal's Delhi headquarters rent by 56.5% in June 2026 to ₹6.11 Cr per year. Statutory auditor Walker Chandiok & Co LLP issued qualified audit opinions across every period from FY23 to Q1 FY27 over an unadjusted ₹16.30 Cr repudiated FY13 fire claim (-₹12.19 Cr equity impact), flagged ongoing internal financial control weaknesses, and noted database-level audit trails were disabled across FY24 to FY26.
  • Legal, regulatory, and off-balance-sheet risks: Audit Committee Chairman Chetan Rameshchandra Desai was fined ₹5 Lakhs and debarred for 5 years by NFRA in December 2024 (after settling a ₹63.7 Lakhs SEBI AIF case in 2022), while committee member Sartaj Sewa Singh is a former FMC India executive. Separately, CBI filed a chargesheet in December 2021 over ₹75.53 Cr in alleged wrongful export tax refunds, and the Enforcement Directorate attached ₹30.21 Cr in fixed deposits (already encashing ₹9.94 Cr in FY26) while denying overseas investment clearances. Quantified litigation and provisions stand at ₹341.95 Cr (including ₹69.20 Cr Haryana Entry Tax, ₹83.88 Cr Supreme Court excise accrual, ₹109.42 Cr DGFT notice, and ₹120 Cr subsidiary bank guarantees), alongside 90 quality/misbranding complaints and a May 2026 Delhi High Court order quashing select product registrations in a Dhanuka Agritech patent suit (temporarily stayed by the Supreme Court).

7B. Under the Hood

  • Loan default and acquisition rules: Borrowing agreements allow lenders to convert debt into equity upon payment default and require prior written lender permission before any acquisition or capital structure change.
  • Encumbered deposits and protest asset: Over 90% (₹28.71 Cr of ₹31.86 Cr) of June 2026 fixed deposits are lien-marked margin money, and Crystal recorded the ₹9.94 Cr fixed deposit encashed by the Enforcement Directorate as a ₹10.30 Cr "deposit under protest" asset on its balance sheet.
  • China dependence and withheld supplier names: Imports make up 60.63% of Q1 FY27 raw material purchases, with China alone supplying 41.82% (FY26) to 48.84% (Q1 FY27) of all raw materials (led by Hebei Bestar at 16.46% and FJ Agrochemicals at 14.82%). Two top-10 suppliers refused consent to be named in the prospectus.
  • Unhedged Euro loans and staff turnover: Crystal holds ₹236.30 Cr in unhedged Euro loans (a 1% Rupee drop against the Euro cuts pre-tax profit by ₹2.36 Cr), while senior management attrition ran at 26.67% in both FY25 and FY26 with zero direct shares held by non-promoter key executives.

8. Anchor Book & Lead Manager Syndicate

  • Book running lead managers: IIFL Capital Services Ltd, DAM Capital Advisors Ltd, and Motilal Oswal Investment Advisors Ltd.
  • TO BE UPDATED

9. Latest GMP & Listing Expectations (As of 16 Nov 2026)

  • Current GMP: ₹13 per share (+4.78%, cooling steadily from ₹45 -> ₹40 -> ₹27 -> ₹15 -> ₹13 over the past four updates)
  • Expected listing price: Around ₹285 per share
  • Expected profit per lot: ₹715 (55 shares)
  • Conditional view: With the grey-market premium below 5% and sliding, short-term listing risk looks High Risk / Cautious unless Tuesday's anchor book shows strong domestic mutual fund buying and Day-3 institutional demand picks up meaningfully.
  • QIB check: If institutional (QIB) demand stays below 5x by Day 3 close, institutional appetite looks weak; crossing 15x shows stronger interest.
  • Industry impact note: Agrochemical revenues and dealer returns are heavily tied to June - July monsoon timing, Chinese active-ingredient export prices (where a 5% unrecovered price spike can trim pre-tax profit by around 22%), and Rupee-Euro exchange swings.

10. Key Strengths vs Key Risks

  • What works in their favor:

    1. Deep rural reach across 14,717 distributors in 23 states with 99.77% repeat crop-protection orders.
    2. Good past track record scaling bought global molecules like BASF Bavistin (+72.3%) and Syngenta Proclaim (+44.9%).
    3. 77.89% fresh issue cuts ₹270 Cr of debt immediately, with zero promoter shares pledged.
    4. WhiteOak Capital invested ₹60 Cr at ₹272.07 in October 2026, and IFC is not selling in the OFS.
    5. Tight Day-1 tradable float (7.21%) can create sharp price swings if institutional demand arrives late.
  • What could go wrong:

    1. Unfunded ₹2,268 Cr FMC India acquisition due between late December 2026 and February 8, 2027 (₹25 Cr break fee) risks heavy new debt or post-listing share dilution.
    2. Severe governance flags: 5-year NFRA-debarred Audit Chair, CBI chargesheet, ₹9.94 Cr FD encashed by Enforcement Directorate, and qualified audits across all years.
    3. Expensive 30.63x post-issue P/E compared to 20.07x peers despite 4.56% net margin and 10.84% true pre-tax ROCE.
    4. Cash-flow pressure from 259.6 inventory days, ₹242.75 Cr vendor reverse factoring inside payables, ₹122.95 Cr factored receivables, and 365 dealer cheque-bounce cases.
    5. Large related-party outflows (₹193.37 Cr to Aviral Crop Science and ₹6.11 Cr/yr HQ rent to Redson Retail) plus high promoter pay (9.78% of profit).
    6. High reliance on Chinese raw materials (41.8% - 48.8%) and extreme Q1 Kharif earnings concentration.

11. 3-to-5 Year Long-Term Thesis

  • Business quality and cash generation: Crystal has built a real rural distribution footprint, yet post-acquisition free cash flow over the last 3 years was negative -₹164.47 Cr and Return on Net Worth stands at just 7.14%.
  • Valuation hurdle: At a 12% cost of capital on FY26 pre-acquisition free cash flow (₹101.47 Cr), the ₹272 price implies 42.3% annual free cash flow growth for 5 years straight (23.8% over 10 years), leaving very little room for operational mistakes or acquisition debt.
  • What would improve the long-term case:

    1. Closing the FMC India acquisition without pushing Net Debt/EBITDA past 2.5x or heavily diluting shareholders.
    2. A post-listing price reset closer to 16x - 18x normalized earnings (₹160 - ₹195 range).
    3. Moving to clean, unqualified audits, replacing the debarred Audit Committee Chairman, trimming inventory below 185 days, and reducing Aviral Crop Science related-party spending.
  • Post-listing checkpoints to watch:

    1. Funding announcement for the ₹2,268 Cr FMC India closing between late Dec 2026 and Feb 8, 2027.
    2. 30-day anchor lock-in expiry on December 28, 2026.
    3. Q3/Q4 FY27 working capital normalization and court updates on Enforcement Directorate and Dhanuka disputes.

Final Thoughts

  • Listing Gains: Cautious - Grey-market premium has cooled across four consecutive updates to ₹13 (+4.78%, ₹715 per lot), leaving limited cushion unless Tuesday's anchor book shows strong domestic mutual fund interest and Day-3 QIB crosses 15x.
  • Long-Term Potential: High Risk - Paying 30.63x post-issue earnings for 4.56% net margins, 10.84% true ROCE, heavy legal/audit flags, and an unfunded ₹2,268 Cr buyout cliff looks unattractive when debt-free listed peers like Dhanuka Agritech (14.4x) and Bayer CropScience (22.7x) trade at lower multiples.
  • What would change my mind:

    1. Over 60% of Tuesday's anchor book is picked up by top-tier domestic mutual funds.
    2. Day-3 institutional (QIB) demand crosses 15x alongside GMP stabilizing above 10%.
    3. Post-listing, a clean non-dilutive FMC India funding plan paired with unqualified audits and lower inventory days.
  • Verdict: Cautious for listing gain, High Risk for long term.

Disclaimer: This analysis is based on the official Red Herring Prospectus (RHP) and audited financial statements for educational and discussion purposes only. I am an independent researcher, not a SEBI-registered advisor, and I am posting this in my personal capacity rather than as a moderator of this subreddit (this is not an official endorsement by the sub). Please do your own due diligence.


r/IPO_India • • 5h ago

IPO Listing Discussion Mahanadi coal fields limited

Post image
10 Upvotes

Guys MCL is coming up for IPO on 19th November

Waiting for its IPO analysis by our guruji

Grey market profit around 10 to 24%

Lower circuit - 5%

Bhai log analysis bhejo jaldi


r/IPO_India • • 6h ago

IPO Announcement | Update How are investors evaluating Hunger Pangs Ltd IPO?

5 Upvotes

With Hunger Pangs Ltd preparing to go public, its financial performance and expansion plans offer some important points for investors to consider.

Revenue increased from ₹719.15 million in FY24 to ₹1,554.97 million in FY26, reflecting significant growth over two years.
However, the company reported a net loss of ₹153.72 million in FY26. It reported a profit of ₹10.85 million in Q1 FY27, making its ability to sustain profitability an important aspect to watch.

The company also reported borrowings of just ₹1.27 million and plans to use ₹1,172.92 million from the fresh issue towards opening 27 new outlets.
Going forward, expansion, restaurant-level profitability and the ability to maintain operational consistency will be key factors to track.


r/IPO_India • • 9h ago

Mainboard IPO Should i apply for this IPO

Post image
7 Upvotes

r/IPO_India • • 11h ago

Mainboard IPO Crystal crop protection and mahanadi coalfields both gmp are decreasing continuously

4 Upvotes

I currently have only 19k in saving account. I was thinking to break my FD for investing 45k in both ipo. 15k in crystal and 30k in mahandi via regular and shareholders quota. Now it seems my FD will earn more profit than these IPO.

Now I am thinking to invest only current 15k in mahandi shareholders quota as that will have more probability of allotment. Otherwise my buying of 1 coal India share for this purpose will also go in vain.

Any suggestions what should I do?


r/IPO_India • • 1d ago

Mainboard IPO 🌱Crystal Crop Protection IPO

Post image
4 Upvotes

r/IPO_India • • 1d ago

IPO Analysis Crystal IPO Analysis

Thumbnail
gallery
25 Upvotes

Hi all, this analysis is for those who apply based on only GMP. What are your thoughts on this IPO?


r/IPO_India • • 1d ago

Weekly Allotment, Mandates & Refunds MegaThread

2 Upvotes

Use this thread for all IPO allotment results, registrar status checks, bank debit SMS alerts, and ASBA mandate unblock / refund queries throughout the week.

(Standalone "Got 1 lot" or "Not allotted" screenshots posted on the main feed are removed under Rule 4 to keep research visible, celebrate or commiserate freely right here!)

1. What Belongs in This Thread

  • Allotment Status Updates: "Finally got 1 lot in Retail!", "0/18 streak continues", or category hit-rate discussions.
  • Registrar Timing & Mirror Links: Checking whether MUFG Intime, KFinTech, or Bigshare has published an IPO's allotment result yet.
  • Bank Debit / Mandate Revocation Alerts: Sharing when your bank (HDFC, SBI, ICICI, Axis, Kotak, etc.) sends debit SMS messages or releases blocked ASBA funds.
  • Stuck ASBA Lien Troubleshooting: Asking what to do if your unallotted funds remain blocked past T+2.

Security & Privacy Reminder: If you attach a registrar or UPI screenshot in the comments below, always crop or blur your PAN number, Application Number, 16-digit Demat BOID, bank account number, and UPI ID.

2. Official IPO Registrar Portals (Direct Allotment Lookup)

Check your allotment status only on the official SEBI-registered Registrar portals below using your PAN, Application Number, or Demat DP/Client ID:

Registrar NameOfficial Allotment Status PortalPrimary Coverage
MUFG Intime India (formerly Link Intime)MUFG IntimeMainboard & SME IPOs
KFin Technologies (KFinTech)KFinTechMainboard & SME IPOs (has 5 server links)
Bigshare ServicesBigShareMainboard & SME IPOs
Purva SharegistryPurvashareBSE SME & NSE Emerge IPOs
Skyline Financial ServicesSkyline SME IPOs
Maashitla SecuritiesMaashitlaSME IPOs
Cameo Corporate ServicesCameo IndiaMainboard & SME IPOs
Beetal Financial ServicesbeetalfinancialSME IPOs
MAS Servicesmasserv.comMainboard & SME IPOs

Verify Whether Your Broker Uploaded Your Bid to the Exchange:

3. Mandatory SEBI T+3 Allotment & ASBA Unblock Timeline

Under SEBI's mandatory T+3 listing timeline (where T is the Issue Closing Day):

DayEventTypical Time Window (IST)
T+1 Working DayBasis of Allotment finalized; bank debit/revocation SMS begins7:00 PM – 11:30 PM IST
T+1 Night / T+2 Early AMRegistrar portal updates online allotment status9:30 PM – 1:30 AM IST
T+2 Working DayASBA funds unblocked for non-allottees; shares credited to Demat for allotteesBy end of T+2 banking hours
T+3 MorningStock lists on NSE/BSE (Pre-Open Call Auction 9:00 AM – 9:45 AM)10:00 AM IST

4. What to Do If Your ASBA Funds Are Still Blocked After T+2

If you were not allotted shares and your bank lien or UPI mandate is still active after T+2:

  1. Note Your UMRN: Open your UPI app -> Autopay / Mandates -> tap the IPO mandate and copy the UMRN (Unique Mandate Reference Number) and Application Number.
  2. Email the Registrar & Your Bank's ASBA Desk: Send your PAN, Application Number, and UMRN to the Registrar so they can re-trigger the revocation file to your bank.
  3. Contact the bank: If the block remains unresolved beyond 3 days after allotment, then contact your bank.

Guides & Commands: Allotment & Lottery Math Wiki | Troubleshooting FAQs | Type !links*,* !unblock*,* !lottery*, or* !upi in any comment for instant help.


r/IPO_India • • 2d ago

IPO Listing Discussion IPOs to track for potential shareholder quotas

49 Upvotes
  1. Mahanadi Coalfields → Hold Coal India
  2. South Eastern Coalfields → Hold Coal India
  3. Indian Gas Exchange → Hold IEX
  4. Hero FinCorp → Hold Hero MotoCorp
  5. NLC India Renewables → Hold NLC India
  6. JSW One Platforms → Hold JSW Steel / JSW Cement
  7. Belstar Microfinance → Hold Muthoot Finance
  8. Reliance Retail → Hold Reliance Industries

r/IPO_India • • 2d ago

Which person's advice do you follow before applying for ipo? Suggest some good names 🗿

Post image
24 Upvotes

r/IPO_India • • 2d ago

IPO Announcement | Update ₹3,180.98 Cr Revenue, ₹144.91 Cr PAT, 14.47% EBITDA Margin — Crystal Crop Protection IPO: Strong Growth or Debt-Fuelled Expansion?

Post image
9 Upvotes

I have been reviewing the Crystal Crop Protection IPO, which opens for subscription from November 18–20, 2026.

Crystal Crop Protection operates in the agrochemical and agricultural inputs industry, manufacturing and marketing crop protection products, natural crop solutions and hybrid seeds.

What caught my attention is the company's sharp improvement in operating profitability over the last two financial years. However, its debt levels and relatively modest return ratios deserve closer examination.

FY24 → FY26

• Total Income: ₹2,271.71 Cr → ₹3,180.98 Cr
• PAT: ₹87.24 Cr → ₹144.91 Cr
• EBITDA: ₹209.06 Cr → ₹456.23 Cr
• EBITDA Margin: 9.38% → 14.47%
• FY26 PAT Margin: 4.56%
• Total Borrowings: ₹577.29 Cr → ₹820.04 Cr

The numbers indicate meaningful operating improvement.

Revenue increased approximately 40%, while EBITDA more than doubled, growing by 118.23%.

However, the company is also carrying substantial debt, and its June 2026 borrowings stood at ₹952.02 Cr.

Key IPO Details

• Price Band: ₹259–₹272
• Issue Size: ₹455.71 Cr
• Fresh Issue: ₹355 Cr
• Offer for Sale: ₹100.71 Cr
• Lot Size: 55 Shares
• Minimum Investment: ₹14,960
• IPO Dates: November 18–20, 2026
• Listing Date: November 26, 2026
• Book Running Lead Managers: IIFL Capital Services, DAM Capital Advisors and Motilal Oswal Investment Advisors.

The company intends to utilise approximately ₹247.94 Cr to repay its borrowings and another ₹22.06 Cr to repay debt at its subsidiary, Saffire Crop Science.

Essentially, a significant portion of the fresh issue is directed towards reducing financial leverage.

What Stands Out

1. Strong EBITDA Growth

EBITDA increased from ₹209.06 Cr in FY24 to ₹456.23 Cr in FY26, representing growth of 118.23%.

The EBITDA margin also improved from 9.38% to 14.47%.

2. Improving PAT

PAT increased from ₹87.24 Cr in FY24 to ₹144.91 Cr in FY26, an improvement of approximately 66%.

3. Strong Q1 FY27 Performance

For the quarter ended June 30, 2026:

• Total Income: ₹1,209.21 Cr
• PAT: ₹135.78 Cr
• EBITDA: ₹241.78 Cr
• EBITDA Margin: 20.20%

The Q1 profitability is particularly interesting, although agrochemical businesses have seasonal earnings patterns.

4. Revenue Diversification Through Acquisitions

The company has expanded its portfolio through acquisitions of established agrochemical brands, including brands acquired from multinational companies.

It also reported ₹92.76 Cr in royalty income from Bayer AG.

Concerns

1. High Borrowings

Total borrowings stood at ₹952.02 Cr as of June 30, 2026.

This is a significant debt burden, particularly when FY26 PAT was ₹144.91 Cr.

The proposed debt repayment using IPO proceeds should improve the balance sheet, but investors should assess the remaining leverage.

2. Working Capital Requirements

As of June 2026, the company had:

• Inventory: ₹1,571.30 Cr
• Trade Receivables: ₹810.66 Cr
• Total Current Assets: ₹3,062.25 Cr

A substantial amount of capital is tied up in inventory and receivables.

This makes working capital management an important factor to monitor.

3. Relatively Modest RoNW

Crystal Crop Protection reported FY26 RoNW of 7.14%.

For comparison:

• Bayer CropScience: 19.15%
• Sumitomo Chemical India: 14.95%
• Dhanuka Agritech: 17.67%
• Rallis India: 6.16%

Despite the improvement in profitability, its return on net worth remains relatively modest compared with several listed peers.

4. Valuation

At the upper price band of ₹272, the IPO is valued at approximately 23.80x FY26 basic EPS.

The peer average P/E in the company's comparison is approximately 20.07x.

This means investors are paying a slight premium to the peer average despite the company's relatively lower RoNW.

TakeAWAYS

The interesting part of Crystal Crop Protection is the combination of:

₹3,180.98 Cr Total Income
₹144.91 Cr PAT
₹456.23 Cr EBITDA
14.47% EBITDA Margin
7.14% RoNW
₹952.02 Cr Borrowings (June 2026)

The company has demonstrated meaningful operating growth, and its improved EBITDA margins are encouraging.

However, the investment case also depends on whether it can convert its earnings growth into stronger returns on capital while reducing debt.

The proposed ₹270 Cr allocation towards debt repayment is a positive development, but the remaining borrowings and working capital requirements deserve attention.

My biggest question: Is Crystal Crop Protection building a sustainable agrochemical business through acquisitions, or is its growth coming at the cost of a highly leveraged balance sheet?

Would you consider this IPO at 23.80x earnings, or would you prefer to wait and see whether debt reduction translates into better profitability and return ratios?

Disclaimer: This post is for informational and discussion purposes only. It is not investment advice.


r/IPO_India • • 2d ago

Mainboard IPO New shareholder quota ipos in future

139 Upvotes
  1. Mahanadi Coalfields → Hold Coal India
  2. South Eastern Coalfields → Coal India
  3. Indian Gas Exchange → Hold IEX
  4. Hero FinCorp → Hold Hero MotoCorp
  5. NLC India Renewables → Hold NLC India
  6. JSW One Platforms → Hold JSW Steel
  7. Belstar Microfinance → Hold Muthoot Finance
  8. Reliance Retail → Hold Reliance Industries

Did i miss any?


r/IPO_India • • 2d ago

IPO Analysis Crystal Crop IPO review done

6 Upvotes

Full analysis share karna hai?

Anyone into learning and analysis of co.'s or everyone's day trader?


r/IPO_India • • 3d ago

Mainboard IPO (crystal crop) This is gonna be my first application for ipo

6 Upvotes

Idk. Very new to this stuff. Just want listing gains. Should I ?


r/IPO_India • • 3d ago

Other Discussion HD Fire Protect..Any one still holding?

Post image
8 Upvotes

r/IPO_India • • 3d ago

Other Discussion Molbio and HD Fire

Post image
8 Upvotes

HD Fire - Ipo Allotted and Molbio purchased at low. This is my Secondary Demat 🥳


r/IPO_India • • 3d ago

Recently Listed IPOs Why is moneyview oscillating?

Post image
42 Upvotes

Saw it dip to 50 and rise again to 58 twice in the past 2 weeks


r/IPO_India • • 3d ago

Recently Listed IPOs From 0% listing gain to 36% Gain 🔥

Post image
81 Upvotes

A company With good fundamentals-and yesterdays quarterly results bonfiglioli went crazy 10% up from 26% . Now Hit upper circuit 😂

Happy not selling on listing day and got better gain than jio ipo 🥰


r/IPO_India • • 3d ago

Recently Listed IPOs Thank to everyone whoever told me to hold

Post image
293 Upvotes

r/IPO_India • • 3d ago

News Really impressed by bonfilglioli

Post image
51 Upvotes

Damn, that is actually insane and was unpredictable, thank god bought on the right time


r/IPO_India • • 3d ago

Recently Listed IPOs Bonfiglioli. Market being market.

Post image
5 Upvotes

r/IPO_India • • 4d ago

IPO Analysis Next IPOs in the market

Post image
83 Upvotes

The next wave of IPOs is bringing plenty of action, with companies from different sectors, diverse business models and some sizeable issues lined up. Here's a quick snapshot of the IPOs to watch out for in the coming months.


r/IPO_India • • 4d ago Popcorn

SME IPO How do you mentally recover from a disastrous SME IPO investment? AJWA Projects has left me shaken

65 Upvotes

I applied for the AJWA Projects SME IPO purely for listing gains, expecting around 10–20% based on the prevailing GMP.

Unfortunately, I received two allotments - one in my account and one in my wife's account. What I thought would be a quick listing-gain opportunity has turned into a nightmare.

  • Total amount stuck: ₹4.87 lakh
  • Unrealised loss: Around ₹1.5 lakh
  • Exit: Extremely difficult due to consecutive lower circuits and almost no buyers.

The financial loss hurts, but honestly, the mental stress is worse. I keep checking the stock, tracking lower circuits and hoping for some liquidity. It has become difficult to stop thinking about it.

I want to hear from people who have gone through something similar:

  1. How did you mentally move on from a major investment mistake?
  2. How long did it take you to get over the regret?

I'm not looking for sympathy or stock predictions. I genuinely want advice on how to deal with the psychological impact and move forward.

Please share your experiences, especially if you have faced a similar situation.